←Neurology
Alcohol withdrawal
📚
📚 Library › 🧠 Neurology › Toxic & withdrawal
🍸

Alcohol withdrawal

Timeline, CIWA vs PAWSS, symptom-triggered benzos or phenobarbital, thiamine, and starting AUD treatment.

alcohol withdrawalCIWAPAWSSphenobarbitalDTsthiamine
🗓️ Reviewed 2026-11-18 · ⏱️ 3 min read · 📖 2020 ASAM alcohol withdrawal guideline · SHM/ACCP reviews
🧠 Pathophysiology in 60 seconds🔎 Timeline💊 Management⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Screen everyone with alcohol use: PAWSS ≥4 = high risk of complicated withdrawal.
  • Symptom-triggered benzodiazepines (CIWA-Ar ≥8–10) for most. CIWA needs a patient who can talk.
  • Severe / resistant / DTs → phenobarbital (or escalating benzos) → ICU.
  • Thiamine before glucose. Wernicke risk → thiamine 200–500 mg IV TID.
  • Start AUD treatment before discharge (naltrexone, acamprosate, gabapentin) + linkage.

🧠 Pathophysiology in 60 seconds

⌄
  • Chronic alcohol boosts GABA-A and blocks NMDA. The brain adapts: fewer GABA receptors, more NMDA receptors.
  • Stop alcohol → too little inhibition, too much excitation → tremor, sympathetic surge, seizures, delirium.
  • Each withdrawal episode makes the next one worse (kindling).
  • Benzodiazepines and phenobarbital replace the missing GABA effect; phenobarbital also blocks glutamate.

🔎 Timeline

⌄
Hours after last drink Syndrome
6–24 h Minor withdrawal: tremor, anxiety, sweats, tachycardia, insomnia
12–48 h Withdrawal seizures (generalized, brief)
12–48 h Alcoholic hallucinosis (clear sensorium)
48–96 h Delirium tremens: confusion, autonomic instability, fever — mortality 1–5% treated
PAWSS items (examples)
Prior withdrawal, prior seizures/DTs, prior alcohol rehab, blackouts, combined with downers, other drug use, BAC >200 on arrival, autonomic hyperactivity (HR >120, tremor, sweats)

Rule out: hypoglycemia, infection (meningitis, pneumonia), head injury (subdural!), hepatic encephalopathy, other drug withdrawal/toxicity.

💊 Management

⌄
  • Symptom-triggered (CIWA ≥8–10): lorazepam 1–4 mg (liver disease, elderly) or chlordiazepoxide 25–100 mg / diazepam 10–20 mg (long-acting, smoother).
  • Front-loading diazepam 10–20 mg IV q5–10 min for severe agitation.
  • Escalating doses without response → benzodiazepine-resistant → phenobarbital, ICU.
  • Single load 10 mg/kg IV (ideal body weight) over 30 min (some protocols 10–15 mg/kg) — self-tapers (long half-life).
  • Or as add-on 130–260 mg IV boluses.
  • Watch sedation and breathing, especially combined with benzos.
  • Thiamine: 100 mg daily if low risk; 200–500 mg IV TID × 3–5 days if Wernicke suspected (confusion, ataxia, ophthalmoplegia — often only one sign).
  • Folate, multivitamin. Replete K, Mg, Phos (refeeding).
  • Avoid antipsychotics alone (lower seizure threshold) — only as adjunct for hallucinations.
  • Dexmedetomidine: adjunct for autonomic signs, does not prevent seizures.
Drug Note
Naltrexone 50 mg daily / 380 mg IM monthly Not with opioids or acute hepatitis/liver failure
Acamprosate 666 mg TID Safe in liver disease; dose-reduce CrCl 30–50, avoid <30
Gabapentin 300–600 mg TID Also helps mild withdrawal/insomnia
Baclofen Option in cirrhosis
Topiramate Off-label

⚠️ Pitfalls

⌄
  • CIWA scoring in a delirious, intubated or non-verbal patient.
  • Giving glucose before thiamine.
  • Missing a subdural hematoma or meningitis as the cause of "DTs."
  • Discharging without AUD medication or follow-up.

🎓 Board corner

⌄
Stem Answer
Day 3 after admission: fever, tachycardia, confusion, hallucinations Delirium tremens
Hallucinations, oriented, normal vitals, 24 h after last drink Alcoholic hallucinosis
Confusion, ataxia, nystagmus Wernicke → high-dose IV thiamine
Withdrawal + cirrhosis — which benzo? Lorazepam (or oxazepam)
AUD + cirrhosis — which relapse drug? Acamprosate or baclofen

📚 References

⌄
  • ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. J Addict Med. 2020;14(3S Suppl 1):1.
  • Maldonado JR, et al. PAWSS. Alcohol Alcohol. 2014;49:477.
  • Rosenson J, et al. Phenobarbital for acute alcohol withdrawal: a prospective RCT. J Emerg Med. 2013;44:592.
↩︎ Back to 🧠 Neurology